KUALA LUMPUR: Maybank Investment Bank Research (Maybank IB) has upgraded its outlook on Mah Sing Group Bhd on the back of its new venture into healthcare-related products and potential policy-easing measures, which could lift buying interest in properties.
“We raise our target price to 64 sen and upgrade Mah Sing to tactical buy, ” said the research house. According to Maybank IB, Mah Sing is exploring growth opportunity in healthcare via its plastic division, which has its own team and is sepately operated from the property business.